Published by news degree
Posted on August 2, 2021
Rising prevalence of cancer, growing standardization of pathological laboratories, technological advancements in diagnostic and molecular techniques for histology and cytology procedures, and favorable reimbursements for cancer screening and laboratory tests are major factors contributing to high CAGR of Histology and Cytology market during the forecast period.
According to the recent analysis of Reports and Data, the global histology and cytology market was valued at USD 11,057.7 million in 2018 and is expected to reach USD 30,543.4 million by the year 2026, exhibiting a CAGR of 13.6%. Histology and Cytology procedures are related to the diagnosis of diseases and other conditions. Histology is the study of human tissues, which includes structure and function, whereas cytology is the study of human cells. Histology and cytology market had experienced a huge growth with regards to healthcare industries as several fatal diseases can be diagnosed through these clinical studies.
Currently, use of molecular techniques is a widely accepted method in histology and cytology as an enabler of morphology for diagnosing and prognosing. Moreover, the study of markers of therapeutic response has been helpful in some types of neoplasms for diagnosing cancer. There are numerous advantages in the use of cytological material to perform molecular studies: ease of obtaining fresh sample, ability to check the quality of the sample immediately after draw and better preservation of DNA and RNA. The possibility of using genomic and proteomic research in small quantities of sample obtained by fine-needle aspiration (ENA) can minimize invasive procedures and allow the monitoring of cancer, thereby increasing the demand of histology and cytology procedures. PCR, microarrays, proteomic and other sequencing methodologies are now being validated in cytological samples. Proper specimen processing is of utmost importance in maintaining morphology and nucleic acid integrity. The role of the cytopathologist is mandatory in the collection and selection of cells. Histopathology evaluation basically compares diseased or experimentally altered tissues with matching sample from healthy or control counterparts. Therefore, it is very important to rigor-ously standardize every histology process (i.e., specimen sam-pling, trimming, embedding, sectioning, and staining). Cytology allows the identification of malignancy from a small quantity of cells. Cervical Pap smears are the most widely accepted example of this kind of testing and have dramatically reduced the incidence of cervical carcinoma. Cytology provides patients a minimally or non-invasive means of obtaining samples and allows analysis of samples such as exfoliated cells in sputum and urine, and pleural, pericardial, cyst fluids. Fine needle aspiration provides cell samples from small lesions, and under image guidance from inaccessible sites such as the lung, head of pancreas and para-aortic lymph nodes. Specimens are often very small and to obtain maximum utility, the process should be performed by trained technicians and using proper and high-end cytology and histology equipment. Growing awareness about the screening of cancer and technological advancements in the cell and tissue studies are likely to boost the demand during the forecast period. An increasing number of well-equipped clinical laboratories in developing countries and favorable reimbursement for cancer screening and laboratory tests are likely to propel market growth. Advancements in cytology and histology save time for pathologists, making the service more cost-effective. Low cost, high sensitivity, and adequate specificity associated with cytology examination procedure will further bolster the histology and cytology market growth. Efficient testing of samples can result in cost-saving and faster outcomes to patients and increasing awareness of individuals about their health. Stringent regulation is one of the key factors for hampering the growth of histology and cytology market.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2194
The use of histology and cytology in the diagnosis of infectious diseases has been well established. Microscopic identification of a virus or bacteria by its morphological features on staining continues to be the accepted means of diagnostic histology; but recent developments in immunohistochemistry and molecular diagnostics will definitely be more rapid and also specific. However, the routine histological identification of pathogens cannot replace conventional microbiologic culture techniques. The successful characterization of the infectious disease pathology requires the proper characterization of the inflammatory response, knowledge of associated pathogens, use of special histology and cytology-based stains and, in some instances, use of highly specific molecular technologies. If microbiologists, pathologists, clinicians and equipment manufacturers work together, timely and often proper diagnosis of many difficult-to-diagnose diseases can be efficiently executed. Before culturing, all biopsies should be investigated for the presence of pathogen or suggestive features leading to infection. Important information is often missed if careful microscopic visualization of the tissue sample is not carried out, thus, there is an urgent need for effective histology and cytology techniques to diagnose chronic diseases.
Further key findings from the report suggest
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/2194
For this report, Reports and Data have segmented the Histology and cytology market based on type, disease type, treatment type, test type, end-use and region:
Type of Examination in Histology and Cytology market (Revenue, USD Million; 2016–2026)
Test Type in Histology and Cytology market (Revenue, USD Million; 2016–2026)
End-use of Histology and Cytology market (Revenue, USD Million; 2016–2026)
Regional Outlook of Histology and Cytology market (Revenue in USD Million; 2016–2026)
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2194
Key Questions Answered by the Report:
Thank you for reading our report. Please connect with us to know more about the report or for requesting customization of the report. Our team will ensure the report is best suited to meet your requirements.
Explore Reports and Data’s Prime Analysis of the global Healthcare & Pharmaceutical Industry:
Active Pharmaceutical Ingredients (API) Market By Type of Synthesis (Synthetic APIs, Biotech APIs), By Type of Manufacturer (Captive APIs, Merchant APIs), By Type (Generic APIs, Innovative APIs), By Application, By Region, And Segment Forecasts, 2016-2027
Acute Ischemia Monitors Market by Product-Type (Benchtop and Portable), End-Users (Operating room, Surgical recovery, Critical care, Emergency room, and Long term care) – Global Forecast 2026 Is Forecasted to Reach USD 2.58 Billion By 2026
Hemolysis Agent for Blood Cell Analyzer Market By Product Type (Less than 500 ml, 500-2000 ml, 2000 ml), By Applications (Clinical, Analytical Research, Others), By End User (Hospitals, Diagnostic Centers, Pharmaceutical Companies) And Segment Forecasts, 2016-2026
Antibody Production Market By Class (Monoclonal antibodies, Murine, Chimeric, Humanized, Polyclonal Antibodies), End User (Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, Research Institutes), By Process And Segment Forecasts, 2016-2026
Left Ventricular Assist Device (LVAD) Market Size, Share & Analysis, By Type (Transcutaneous LVAD and Implantable LVAD), By Age group, By Pump type, Application and By End-user And Segment Forecasts, 2016-2026
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Read Full Press Release: https://www.reportsanddata.com/press-release/global-histology-and-cytology-market
The post Histology and Cytology Market Growth To Reach USD 30,543.4 Million By 2026 – Reports and Data first appeared on News Degree | Hub for Latest and Trending News from Around the Globe.
Rising prevalence of cancer, growing standardization of pathological laboratories, technological advancements in diagnostic and molecular techniques for histology and cytology procedures, and favorable reimbursements for cancer screening and laboratory tests are major factors contributing to high CAGR of Histology and Cytology market during the forecast period.
According to the recent analysis of Reports and Data, the global histology and cytology market was valued at USD 11,057.7 million in 2018 and is expected to reach USD 30,543.4 million by the year 2026, exhibiting a CAGR of 13.6%. Histology and Cytology procedures are related to the diagnosis of diseases and other conditions. Histology is the study of human tissues, which includes structure and function, whereas cytology is the study of human cells. Histology and cytology market had experienced a huge growth with regards to healthcare industries as several fatal diseases can be diagnosed through these clinical studies.
Currently, use of molecular techniques is a widely accepted method in histology and cytology as an enabler of morphology for diagnosing and prognosing. Moreover, the study of markers of therapeutic response has been helpful in some types of neoplasms for diagnosing cancer. There are numerous advantages in the use of cytological material to perform molecular studies: ease of obtaining fresh sample, ability to check the quality of the sample immediately after draw and better preservation of DNA and RNA. The possibility of using genomic and proteomic research in small quantities of sample obtained by fine-needle aspiration (ENA) can minimize invasive procedures and allow the monitoring of cancer, thereby increasing the demand of histology and cytology procedures. PCR, microarrays, proteomic and other sequencing methodologies are now being validated in cytological samples. Proper specimen processing is of utmost importance in maintaining morphology and nucleic acid integrity. The role of the cytopathologist is mandatory in the collection and selection of cells. Histopathology evaluation basically compares diseased or experimentally altered tissues with matching sample from healthy or control counterparts. Therefore, it is very important to rigor-ously standardize every histology process (i.e., specimen sam-pling, trimming, embedding, sectioning, and staining). Cytology allows the identification of malignancy from a small quantity of cells. Cervical Pap smears are the most widely accepted example of this kind of testing and have dramatically reduced the incidence of cervical carcinoma. Cytology provides patients a minimally or non-invasive means of obtaining samples and allows analysis of samples such as exfoliated cells in sputum and urine, and pleural, pericardial, cyst fluids. Fine needle aspiration provides cell samples from small lesions, and under image guidance from inaccessible sites such as the lung, head of pancreas and para-aortic lymph nodes. Specimens are often very small and to obtain maximum utility, the process should be performed by trained technicians and using proper and high-end cytology and histology equipment. Growing awareness about the screening of cancer and technological advancements in the cell and tissue studies are likely to boost the demand during the forecast period. An increasing number of well-equipped clinical laboratories in developing countries and favorable reimbursement for cancer screening and laboratory tests are likely to propel market growth. Advancements in cytology and histology save time for pathologists, making the service more cost-effective. Low cost, high sensitivity, and adequate specificity associated with cytology examination procedure will further bolster the histology and cytology market growth. Efficient testing of samples can result in cost-saving and faster outcomes to patients and increasing awareness of individuals about their health. Stringent regulation is one of the key factors for hampering the growth of histology and cytology market.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2194
The use of histology and cytology in the diagnosis of infectious diseases has been well established. Microscopic identification of a virus or bacteria by its morphological features on staining continues to be the accepted means of diagnostic histology; but recent developments in immunohistochemistry and molecular diagnostics will definitely be more rapid and also specific. However, the routine histological identification of pathogens cannot replace conventional microbiologic culture techniques. The successful characterization of the infectious disease pathology requires the proper characterization of the inflammatory response, knowledge of associated pathogens, use of special histology and cytology-based stains and, in some instances, use of highly specific molecular technologies. If microbiologists, pathologists, clinicians and equipment manufacturers work together, timely and often proper diagnosis of many difficult-to-diagnose diseases can be efficiently executed. Before culturing, all biopsies should be investigated for the presence of pathogen or suggestive features leading to infection. Important information is often missed if careful microscopic visualization of the tissue sample is not carried out, thus, there is an urgent need for effective histology and cytology techniques to diagnose chronic diseases.
Further key findings from the report suggest
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/2194
For this report, Reports and Data have segmented the Histology and cytology market based on type, disease type, treatment type, test type, end-use and region:
Type of Examination in Histology and Cytology market (Revenue, USD Million; 2016–2026)
Test Type in Histology and Cytology market (Revenue, USD Million; 2016–2026)
End-use of Histology and Cytology market (Revenue, USD Million; 2016–2026)
Regional Outlook of Histology and Cytology market (Revenue in USD Million; 2016–2026)
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2194
Key Questions Answered by the Report:
Thank you for reading our report. Please connect with us to know more about the report or for requesting customization of the report. Our team will ensure the report is best suited to meet your requirements.
Explore Reports and Data’s Prime Analysis of the global Healthcare & Pharmaceutical Industry:
Active Pharmaceutical Ingredients (API) Market By Type of Synthesis (Synthetic APIs, Biotech APIs), By Type of Manufacturer (Captive APIs, Merchant APIs), By Type (Generic APIs, Innovative APIs), By Application, By Region, And Segment Forecasts, 2016-2027
Acute Ischemia Monitors Market by Product-Type (Benchtop and Portable), End-Users (Operating room, Surgical recovery, Critical care, Emergency room, and Long term care) – Global Forecast 2026 Is Forecasted to Reach USD 2.58 Billion By 2026
Hemolysis Agent for Blood Cell Analyzer Market By Product Type (Less than 500 ml, 500-2000 ml, 2000 ml), By Applications (Clinical, Analytical Research, Others), By End User (Hospitals, Diagnostic Centers, Pharmaceutical Companies) And Segment Forecasts, 2016-2026
Antibody Production Market By Class (Monoclonal antibodies, Murine, Chimeric, Humanized, Polyclonal Antibodies), End User (Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, Research Institutes), By Process And Segment Forecasts, 2016-2026
Left Ventricular Assist Device (LVAD) Market Size, Share & Analysis, By Type (Transcutaneous LVAD and Implantable LVAD), By Age group, By Pump type, Application and By End-user And Segment Forecasts, 2016-2026
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Read Full Press Release: https://www.reportsanddata.com/press-release/global-histology-and-cytology-market
The post Histology and Cytology Market Growth To Reach USD 30,543.4 Million By 2026 – Reports and Data first appeared on News Degree | Hub for Latest and Trending News from Around the Globe.
Explore more articles in the Research Reports category
